Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market is Anticipated to Attain a Valuation of US$ 39.5 Bn Steady CAGR of 4.7% by the end of year 2028. Analysis by Future Market Insights, Inc. NEWARK, Del, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The global benign prostatic hyperplasia (BPH) prostate treatment market is expected to reach a valuation of US$ 39.5 Bn in 2028, with demand growing at...

Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market to Grow at a CAGR of ~6% during 2023-2033; Market to Expand Owing to the Growing Rate of BPH Surgical Treatment and Rising Geriatric Population –Research Nester New York, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Research Nester has published a detailed market report on ‘Global Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market’ for the forecast period,...